Formulation and Development of HA BSA Coated NLC Containing Fisetin and Flavokawain A for the Treatment of Lung Carcinoma. JOC 2025, 24 (8s), 553-562. https://doi.org/10.64149/J.Carcinog.24.8s.553-562.